---
title: "ANI Pharmaceuticals SVP, General Counsel Meredith Cook disposes of 500 common shares for $40,920"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292669404.md"
description: "ANI Pharmaceuticals Senior Vice President and General Counsel Meredith W. Cook sold 500 common shares on July 13, 2026, at $81.84 per share, totaling $40,920. Following the transaction, Cook retained a holding of 77,390 ANI Pharmaceuticals common shares."
datetime: "2026-07-14T20:02:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292669404.md)
  - [en](https://longbridge.com/en/news/292669404.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292669404.md)
generator: "portal-rs"
---

# ANI Pharmaceuticals SVP, General Counsel Meredith Cook disposes of 500 common shares for $40,920

-   ANI Pharmaceuticals officer Meredith W. Cook, senior vice president, general counsel and secretary, sold 500 common shares on July 13, 2026. \* Sale priced at USD 81.84 per share. \* Cook held 77,390 ANI Pharmaceuticals common shares after the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ANI Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001938861-26-000019), on July 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ANIP.US](https://longbridge.com/en/quote/ANIP.US.md)

## Related News & Research

- [ANI Pharma SVP, CFO Stephen P. Carey sells 2,850 shares for $207,480](https://longbridge.com/en/news/297704077.md)
- [ANI Pharma CEO Nikhil Lalwani disposes of 5,400 common shares worth $401,220](https://longbridge.com/en/news/297093829.md)
- [4,000 Shares in Ligand Pharmaceuticals Incorporated $LGND Acquired by JW Asset Management LLC](https://longbridge.com/en/news/298374596.md)
- [KALA BIO Updates Annual Meeting and Proposal Deadlines](https://longbridge.com/en/news/298510459.md)
- [Jazz Pharma CEO Renee D. Gala disposes of ordinary shares worth $970,664.07](https://longbridge.com/en/news/298641896.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**